Olema Pharmaceuticals Inc. (OLMA) NASDAQ
$9.84 0.18 (1.86%)
Market Cap: $550.39M
As of 05/17/24 04:00 PM EDT. Market closed.
Olema Pharmaceuticals Inc. (OLMA)
NASDAQ
$9.84
0.18 (1.86%)
Market Cap: $550.39M
As of 05/17/24 04:00 PM EDT. Market closed.
Add to Portfolio
olema oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. our lead program, op-1250, a potential best-in-class complete estrogen receptor antagonist (ceran), is in development to treat estrogen receptor-positive (er+), human epidermal growth factor receptor 2-negative (her2-) breast cancer. olema recently initiated a phase 1/2 dose-escalation ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
83
Address
.
PRICE CHART FOR OLEMA PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.78
Previous Close
$9.66
Days Range
$9.66 - $10.01
52 week range
$5.02 - $17.79
Volume
547,955
Avg. Volume (30 days)
776,408
Market Cap
$550.39M
Dividend Yield
-
P/E
-
Shares Outstanding
55,933,827
Open
$9.78
Previous Close
$9.66
Days Range
$9.66 - $10.01
52 week range
$5.02 - $17.79
Volume
547,955
Avg. Volume (30 days)
776,408
Market Cap
$550.39M
Dividend Yield
-
P/E
-
Shares Outstanding
55,933,827
FINANCIAL STATEMENTS FOR OLEMA PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR OLEMA PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Harmon Cyrus | Director | May 06, 2024 | Sale | $10.92 | 5,000 | 54,600 | 806,283 | May 07, 2024, 05:00 PM |
| Harmon Cyrus | Director | Apr 30, 2024 | Sale | $9.51 | 15,000 | 142,650 | 811,283 | May 02, 2024, 05:09 PM |
| Harmon Cyrus | Director | Mar 28, 2024 | Sale | $10.97 | 20,000 | 219,400 | 826,283 | Mar 29, 2024, 05:00 PM |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Mar 18, 2024 | Option Exercise | $4.87 | 13,700 | 66,719 | 80,364 | Mar 20, 2024, 05:30 PM |
| Harmon Cyrus | Director | Feb 29, 2024 | Sale | $12.41 | 25,000 | 310,309 | 846,383 | Mar 04, 2024, 05:30 PM |
| Harmon Cyrus | Director | Feb 01, 2024 | Sale | $15.56 | 5,000 | 77,800 | 871,283 | Feb 02, 2024, 05:00 PM |
| Harmon Cyrus | Director | Jan 31, 2024 | Sale | $12.23 | 25,000 | 305,750 | 876,283 | Feb 02, 2024, 05:00 PM |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Jan 25, 2024 | Option Exercise | $7.02 | 20,000 | 140,400 | 66,664 | Jan 29, 2024, 07:30 AM |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Jan 12, 2024 | Option Exercise | $7.02 | 50,000 | 351,000 | 484,987 | Jan 16, 2024, 07:30 AM |
| Harmon Cyrus | Director | Dec 29, 2023 | Sale | $13.38 | 25,000 | 334,500 | 903,783 | Jan 02, 2024, 05:30 PM |
| Graham G. Walmsley | Director | Dec 05, 2023 | Buy | $14.19 | 131,870 | 1,871,280 | 1,800,000 | Dec 18, 2023, 06:30 PM |
| Graham G. Walmsley | Director | Sep 12, 2023 | Buy | $9.84 | 508,130 | 4,999,999 | 1,668,130 | Dec 18, 2023, 06:30 PM |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Dec 12, 2023 | Option Exercise | $7.02 | 10,000 | 70,200 | 434,987 | Dec 12, 2023, 05:55 PM |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Dec 11, 2023 | Option Exercise | $7.02 | 2,900 | 20,358 | 46,664 | Dec 12, 2023, 05:55 PM |
| Paradigm Biocapital Advisors LP | 10% Owner | Dec 06, 2023 | Buy | $11.60 | 100,000 | 1,160,000 | 6,590,981 | Dec 08, 2023, 04:19 PM |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Dec 06, 2023 | Option Exercise | $7.02 | 13,100 | 91,962 | 43,764 | Dec 07, 2023, 08:30 PM |
| Harmon Cyrus | Director | Nov 30, 2023 | Sale | $12.57 | 25,000 | 314,250 | 926,283 | Dec 01, 2023, 05:15 PM |
| Harmon Cyrus | Director | Nov 22, 2023 | Sale | $13.90 | 3,989 | 55,447 | 951,283 | Nov 22, 2023, 07:00 PM |
| Harmon Cyrus | Director | Nov 21, 2023 | Sale | $14.86 | 4,192 | 62,293 | 955,272 | Nov 22, 2023, 07:00 PM |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Nov 22, 2023 | Sale | $13.89 | 7,095 | 98,550 | 30,664 | Nov 22, 2023, 07:00 PM |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | Nov 21, 2023 | Sale | $14.84 | 7,461 | 110,747 | 37,959 | Nov 22, 2023, 07:00 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 22, 2023 | Sale | $13.89 | 6,653 | 92,410 | 574,099 | Nov 22, 2023, 07:00 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 21, 2023 | Sale | $14.88 | 6,976 | 103,823 | 580,952 | Nov 22, 2023, 07:00 PM |
| Bohen Sean | PRESIDENT AND CEO | Nov 22, 2023 | Sale | $13.90 | 27,932 | 388,255 | 144,925 | Nov 22, 2023, 07:00 PM |
| Bohen Sean | PRESIDENT AND CEO | Nov 21, 2023 | Sale | $14.88 | 29,293 | 435,879 | 175,459 | Nov 22, 2023, 07:00 PM |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Nov 22, 2023 | Sale | $13.89 | 9,145 | 127,024 | 424,987 | Nov 22, 2023, 07:00 PM |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | Nov 21, 2023 | Sale | $14.86 | 9,597 | 142,632 | 434,832 | Nov 22, 2023, 07:00 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 08, 2023 | Sale | $17.61 | 200 | 3,522 | 561,270 | Nov 13, 2023, 05:30 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 02, 2023 | Sale | $15.36 | 3,332 | 51,180 | 562,011 | Nov 03, 2023, 09:39 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 01, 2023 | Sale | $15.02 | 6,668 | 100,153 | 565,343 | Nov 03, 2023, 09:39 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Nov 03, 2023 | Sale | $17.51 | 541 | 9,473 | 561,470 | Nov 03, 2023, 09:39 PM |
| Harmon Cyrus | Director | Nov 02, 2023 | Sale | $15.64 | 5,000 | 78,200 | 943,714 | Nov 02, 2023, 08:50 PM |
| Harmon Cyrus | Director | Oct 31, 2023 | Sale | $12.05 | 25,000 | 301,250 | 948,714 | Nov 02, 2023, 08:50 PM |
| Harmon Cyrus | Director | Sep 29, 2023 | Sale | $12.41 | 25,000 | 310,250 | 973,714 | Oct 03, 2023, 05:00 PM |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | Sep 19, 2023 | Sale | $12.67 | 20,000 | 253,400 | 572,011 | Sep 21, 2023, 05:00 PM |
| BVF PARTNERS L P/IL | Director | Sep 12, 2023 | Buy | $9.84 | 1,505,932 | 14,818,371 | 4,688,954 | Sep 14, 2023, 04:25 PM |
| Harmon Cyrus | Director | Sep 05, 2023 | Sale | $11.62 | 10,000 | 116,200 | 998,714 | Sep 05, 2023, 09:08 PM |
| Harmon Cyrus | Director | Aug 31, 2023 | Sale | $9.36 | 15,000 | 140,400 | 1,008,714 | Sep 05, 2023, 09:08 PM |
| Harmon Cyrus | Director | Aug 16, 2023 | Sale | $10.14 | 15,000 | 152,100 | 1,023,714 | Sep 05, 2023, 04:05 PM |
| Harmon Cyrus | Director | Aug 16, 2023 | Sale | $10.14 | 15,000 | 152,100 | 1,023,714 | Aug 17, 2023, 05:00 PM |
| Harmon Cyrus | Director | Jun 08, 2023 | Sale | $6.30 | 10,000 | 63,000 | 1,038,714 | Jun 09, 2023, 05:30 PM |
| Harmon Cyrus | Director | Jun 05, 2023 | Sale | $6.05 | 5,000 | 30,225 | 1,053,714 | Jun 07, 2023, 09:30 PM |
| Harmon Cyrus | Director | Jun 06, 2023 | Sale | $6.30 | 5,000 | 31,475 | 1,048,714 | Jun 07, 2023, 09:30 PM |
| BVF PARTNERS L P/IL | Director | Jun 10, 2022 | Buy | $4.03 | 200,000 | 806,900 | 3,913,676 | Jun 14, 2022, 04:46 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Mar 10, 2022 | Option Exercise | $2.06 | 5,253 | 10,842 | 7,711 | Mar 14, 2022, 04:45 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Mar 10, 2022 | Sale | $4.75 | 5,253 | 24,952 | 2,458 | Mar 14, 2022, 04:45 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Feb 10, 2022 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,709 | Feb 14, 2022, 05:18 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Jan 10, 2022 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,709 | Jan 11, 2022, 08:21 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Jan 10, 2022 | Sale | $6.85 | 5,251 | 35,969 | 2,458 | Jan 11, 2022, 08:21 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Dec 10, 2021 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,709 | Dec 14, 2021, 04:25 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Dec 10, 2021 | Sale | $10.39 | 5,251 | 54,558 | 2,458 | Dec 14, 2021, 04:25 PM |
| Myles David C. | CHIEF DEVELOPMENT OFFICER | Dec 10, 2021 | Sale | $10.30 | 10,000 | 103,000 | 582,901 | Dec 14, 2021, 04:03 PM |
| BVF PARTNERS L P/IL | Director | Nov 30, 2021 | Buy | $9.39 | 739,675 | 6,945,770 | 3,755,093 | Dec 02, 2021, 08:45 PM |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Nov 29, 2021 | Sale | $24.76 | 400 | 9,904 | 1,051,146 | Dec 01, 2021, 05:34 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Nov 10, 2021 | Option Exercise | $15.79 | 27,668 | 436,761 | 29,458 | Nov 12, 2021, 05:15 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Nov 10, 2021 | Sale | $26.88 | 27,668 | 743,716 | 1,790 | Nov 12, 2021, 05:15 PM |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Oct 19, 2021 | Sale | $27.98 | 12,000 | 335,794 | 1,056,101 | Oct 21, 2021, 04:33 PM |
| Bohen Sean | PRESIDENT AND CEO | Oct 14, 2021 | Option Exercise | $4.82 | 5,000 | 24,120 | 57,514 | Oct 15, 2021, 06:44 PM |
| Bohen Sean | PRESIDENT AND CEO | Oct 14, 2021 | Sale | $30.47 | 5,000 | 152,363 | 52,865 | Oct 15, 2021, 06:44 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Oct 11, 2021 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,041 | Oct 12, 2021, 06:53 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Oct 11, 2021 | Sale | $27.90 | 5,251 | 146,510 | 4,936 | Oct 12, 2021, 06:53 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 27, 2021 | Option Exercise | $4.82 | 1,085 | 5,234 | 53,599 | Sep 29, 2021, 07:56 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 27, 2021 | Sale | $30.07 | 1,085 | 32,626 | 52,514 | Sep 29, 2021, 07:56 PM |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Sep 20, 2021 | Sale | $26.30 | 12,000 | 315,600 | 1,063,546 | Sep 21, 2021, 06:19 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sep 10, 2021 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,041 | Sep 13, 2021, 08:07 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Sep 10, 2021 | Sale | $29.38 | 5,251 | 154,274 | 1,790 | Sep 13, 2021, 08:07 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 07, 2021 | Option Exercise | $4.82 | 413 | 1,992 | 54,687 | Sep 09, 2021, 04:25 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 08, 2021 | Option Exercise | $4.82 | 2,631 | 12,692 | 56,905 | Sep 09, 2021, 04:25 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 07, 2021 | Sale | $30.08 | 413 | 12,423 | 54,274 | Sep 09, 2021, 04:25 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 08, 2021 | Sale | $30.00 | 2,631 | 78,930 | 52,514 | Sep 09, 2021, 04:25 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 01, 2021 | Option Exercise | $4.82 | 871 | 4,202 | 55,145 | Sep 03, 2021, 05:16 PM |
| Bohen Sean | PRESIDENT AND CEO | Sep 01, 2021 | Sale | $30.05 | 871 | 26,174 | 54,274 | Sep 03, 2021, 05:16 PM |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Aug 19, 2021 | Sale | $24.97 | 12,000 | 299,640 | 1,075,546 | Aug 20, 2021, 09:14 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Aug 10, 2021 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,041 | Aug 11, 2021, 06:05 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Aug 10, 2021 | Sale | $25.71 | 5,251 | 134,979 | 1,850 | Aug 11, 2021, 06:05 PM |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Jul 20, 2021 | Sale | $25.63 | 4,123 | 105,672 | 1,087,546 | Jul 21, 2021, 05:29 PM |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | Jul 19, 2021 | Sale | $24.83 | 7,877 | 195,586 | 1,091,669 | Jul 21, 2021, 05:29 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Jul 12, 2021 | Option Exercise | $2.06 | 5,251 | 10,838 | 7,041 | Jul 13, 2021, 06:27 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | Jul 12, 2021 | Sale | $26.51 | 5,251 | 139,191 | 3,182 | Jul 13, 2021, 06:27 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | May 18, 2021 | Option Exercise | $2.06 | 57,763 | 119,223 | 59,553 | May 19, 2021, 08:18 PM |
| Horn Kinney | CHIEF BUSINESS OFFICER | May 18, 2021 | Sale | $24.15 | 57,763 | 1,394,769 | 10,411 | May 19, 2021, 08:18 PM |
| Cormorant Asset Management, LP | Former 10% Owner | Nov 23, 2020 | Buy | $19.00 | 425,000 | 8,075,000 | 3,270,544 | Nov 23, 2020, 04:59 PM |
| Graham G. Walmsley | Director | Nov 23, 2020 | Buy | $19.00 | 1,160,000 | 22,040,000 | 1,160,000 | Nov 23, 2020, 04:35 PM |
| BVF PARTNERS L P/IL | Director | Nov 19, 2020 | Buy | $19.00 | 1,135,334 | 21,571,346 | 3,392,663 | Nov 20, 2020, 08:02 PM |
| BUTITTA CYNTHIA M | Director | Sep 16, 2020 | Option Exercise | $4.41 | 83,876 | 369,558 | 83,876 | Nov 19, 2020, 06:42 PM |
| Bohen Sean | President and CEO | Sep 23, 2020 | Option Exercise | $4.82 | 51,649 | 249,155 | 51,649 | Nov 19, 2020, 06:41 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Harmon Cyrus | Director | 05/06/2024 | 54,600 |
| Harmon Cyrus | Director | 04/30/2024 | 142,650 |
| Harmon Cyrus | Director | 03/28/2024 | 219,400 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 03/18/2024 | 66,719 |
| Harmon Cyrus | Director | 02/29/2024 | 310,309 |
| Harmon Cyrus | Director | 02/01/2024 | 77,800 |
| Harmon Cyrus | Director | 01/31/2024 | 305,750 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 01/25/2024 | 140,400 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 01/12/2024 | 351,000 |
| Harmon Cyrus | Director | 12/29/2023 | 334,500 |
| Graham G. Walmsley | Director | 12/05/2023 | 1,871,280 |
| Graham G. Walmsley | Director | 09/12/2023 | 4,999,999 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 12/12/2023 | 70,200 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 12/11/2023 | 20,358 |
| Paradigm Biocapital Advisors LP | 10% Owner | 12/06/2023 | 1,160,000 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 12/06/2023 | 91,962 |
| Harmon Cyrus | Director | 11/30/2023 | 314,250 |
| Harmon Cyrus | Director | 11/22/2023 | 55,447 |
| Harmon Cyrus | Director | 11/21/2023 | 62,293 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 11/22/2023 | 98,550 |
| Zojwalla Naseem | CHIEF MEDICAL OFFICER | 11/21/2023 | 110,747 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 11/22/2023 | 92,410 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 11/21/2023 | 103,823 |
| Bohen Sean | PRESIDENT AND CEO | 11/22/2023 | 388,255 |
| Bohen Sean | PRESIDENT AND CEO | 11/21/2023 | 435,879 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 11/22/2023 | 127,024 |
| Kovacs Shane William Charles | CH. OPERATING & FINANCIAL OFF. | 11/21/2023 | 142,632 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 11/08/2023 | 3,522 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 11/02/2023 | 51,180 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 11/01/2023 | 100,153 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 11/03/2023 | 9,473 |
| Harmon Cyrus | Director | 11/02/2023 | 78,200 |
| Harmon Cyrus | Director | 10/31/2023 | 301,250 |
| Harmon Cyrus | Director | 09/29/2023 | 310,250 |
| Myles David C. | CH. DISCOV. & NON-CLIN DEV OFF | 09/19/2023 | 253,400 |
| BVF PARTNERS L P/IL | Director | 09/12/2023 | 14,818,371 |
| Harmon Cyrus | Director | 09/05/2023 | 116,200 |
| Harmon Cyrus | Director | 08/31/2023 | 140,400 |
| Harmon Cyrus | Director | 08/16/2023 | 152,100 |
| Harmon Cyrus | Director | 08/16/2023 | 152,100 |
| Harmon Cyrus | Director | 06/08/2023 | 63,000 |
| Harmon Cyrus | Director | 06/05/2023 | 30,225 |
| Harmon Cyrus | Director | 06/06/2023 | 31,475 |
| BVF PARTNERS L P/IL | Director | 06/10/2022 | 806,900 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 03/10/2022 | 10,842 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 03/10/2022 | 24,952 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 02/10/2022 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 01/10/2022 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 01/10/2022 | 35,969 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 12/10/2021 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 12/10/2021 | 54,558 |
| Myles David C. | CHIEF DEVELOPMENT OFFICER | 12/10/2021 | 103,000 |
| BVF PARTNERS L P/IL | Director | 11/30/2021 | 6,945,770 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 11/29/2021 | 9,904 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 11/10/2021 | 436,761 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 11/10/2021 | 743,716 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 10/19/2021 | 335,794 |
| Bohen Sean | PRESIDENT AND CEO | 10/14/2021 | 24,120 |
| Bohen Sean | PRESIDENT AND CEO | 10/14/2021 | 152,363 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 10/11/2021 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 10/11/2021 | 146,510 |
| Bohen Sean | PRESIDENT AND CEO | 09/27/2021 | 5,234 |
| Bohen Sean | PRESIDENT AND CEO | 09/27/2021 | 32,626 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 09/20/2021 | 315,600 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 09/10/2021 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 09/10/2021 | 154,274 |
| Bohen Sean | PRESIDENT AND CEO | 09/07/2021 | 1,992 |
| Bohen Sean | PRESIDENT AND CEO | 09/08/2021 | 12,692 |
| Bohen Sean | PRESIDENT AND CEO | 09/07/2021 | 12,423 |
| Bohen Sean | PRESIDENT AND CEO | 09/08/2021 | 78,930 |
| Bohen Sean | PRESIDENT AND CEO | 09/01/2021 | 4,202 |
| Bohen Sean | PRESIDENT AND CEO | 09/01/2021 | 26,174 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 08/19/2021 | 299,640 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 08/10/2021 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 08/10/2021 | 134,979 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 07/20/2021 | 105,672 |
| Harmon Cyrus | CHIEF TECHNOLOGY OFFICER | 07/19/2021 | 195,586 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 07/12/2021 | 10,838 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 07/12/2021 | 139,191 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 05/18/2021 | 119,223 |
| Horn Kinney | CHIEF BUSINESS OFFICER | 05/18/2021 | 1,394,769 |
| Cormorant Asset Management, LP | Former 10% Owner | 11/23/2020 | 8,075,000 |
| Graham G. Walmsley | Director | 11/23/2020 | 22,040,000 |
| BVF PARTNERS L P/IL | Director | 11/19/2020 | 21,571,346 |
| BUTITTA CYNTHIA M | Director | 09/16/2020 | 369,558 |
| Bohen Sean | President and CEO | 09/23/2020 | 249,155 |
Load More Insider Transactions
FUNDS WITH A POSITION IN OLEMA PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 3,216,554 | 0.00085% | -1.45% | Other |
| VIVO CAPITAL, LLC | 1,873,704 | 1.67% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 839,345 | 0.00088% | 1.76% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 460,000 | 0.00983% | -8% | Other |
| CANDRIAM S.C.A. | 353,018 | 0.03% | 64.19% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 173,611 | 0.00377% | Exited | Other |
| ALPS ADVISORS INC | 38,861 | 0.00311% | 1.83% | Other |
| D. E. SHAW & CO., INC. | 10,100 | 0.0001% | -15.05% | Other |
| AQR CAPITAL MANAGEMENT LLC | 11,421 | 0.00022% | 5.94% | Other |
CHANGE IN SHARES OUTSTANDING FOR OLEMA PHARMACEUTICALS INC
STOCK BUYBACKS FOR OLEMA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.60%
1Q
06/30/2023
11.12%
2Q
03/31/2023
12.12%
3Q
12/31/2022
12.58%
4Q
09/30/2022
13.02%
5Q
06/30/2022
13.35%
6Q
03/31/2022
13.59%
7Q
12/31/2021
13.84%
8Q
09/30/2021
14.24%
9Q
06/30/2021
14.80%
10Q
03/31/2021
15.06%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OLEMA PHARMACEUTICALS INC
LOADING...